Immunosuppressive drugs and diet interact to modify the gut microbiota and cardiovascular risk factors, and to trigger diabetes
The IST and the HFD have specific consequences on the gut microbiota and metabolism. We hypothesize that the metabolic consequences are at least partially mediated by IST/HFD-induced dysbiosis.
Authors
- Louis Anjou
- Clara Lefranc (ORCID: https://orcid.org/0000-0003-4635-136X)
- Roberto Palacios (ORCID: https://orcid.org/0000-0002-0867-1277)
- Kevin Pérez (ORCID: https://orcid.org/0000-0002-1802-185X)
- Benjamin Bonnard (ORCID: https://orcid.org/0000-0002-1746-9580)
- Jean-Paul Paı̈s de Barros (ORCID: https://orcid.org/0000-0002-5124-2283)
- Yanis Tamzali (ORCID: https://orcid.org/0000-0003-0710-8869)
- Jérôme Tourret (ORCID: https://orcid.org/0000-0003-2998-6531)
- Frédéric Jaisser (ORCID: https://orcid.org/0000-0001-9051-1901)
- Christopher Loens
- Philippe Seksik (ORCID: https://orcid.org/0000-0003-3596-9893)
- Paul Gabarre
- Noël Zahr
Institutions
- Inserm (FR)
- Université de Bourgogne (FR)
- Sorbonne Université (FR)
- Centre de Recherche des Cordeliers (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Saint-Antoine (FR)
- Pitié-Salpêtrière Hospital (FR)
- Centre de Recherche Saint-Antoine (FR)
- University of Lausanne (CH)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1371/journal.pone.0320438
- Citations
- 1
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Institut National de la Santé et de la Recherche Médicale
- Assistance Publique - Hôpitaux de Paris